关注
Thomas Leth Jensen
Thomas Leth Jensen
Medical Doctor, Department of Clinical Pharmacology, Bispebjerg Hospital, Capital Region of Denmark
在 regionh.dk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Current and future prospects for gene therapy for rare genetic diseases affecting the brain and spinal cord
TL Jensen, CR Gøtzsche, DPD Woldbye
Frontiers in molecular neuroscience 14, 695937, 2021
502021
Repeated poisonings in Denmark–a nationwide study
TL Jensen, M Tejlbo Frost, K Dalhoff, T Studsgaard Petersen
Clinical toxicology 61 (5), 392-399, 2023
12023
The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects
TL Jensen, A Brønden, K Karstoft, DP Sonne, MB Christensen
Patient preference and adherence, 373-382, 2024
2024
Simulationstræning i akut pædiatri
AM Andersen, TL Jensen, JL Sørensen, LK Gjærde, S Lund, L Paulsen, ...
Ugeskrift for Læger 185 (12), V09220581, 2023
2023
Tirzepatide for the treatment of type 2 diabetes and obesity
TL Jensen, A Bronden, K Karstoft, DP Sonne, MB Christensen
DRUGS OF THE FUTURE 48 (3), 179-196, 2023
2023
Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity
TL Jensen, A Bronden, K Karstoft, DP Sonne, MB Christensen
Drugs of the Future 2023, 48(3): 179-196, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–6